General Information of This Drug (ID: DM8L5JR)

Drug Name
PMID25684022-Compound-WO2008107444   DM8L5JR
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Patented Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Patented [1]
Metastatic cancer DISBPS35 2D50-2E2Z Patented [1]
------------------------------------------------------------------------------------

References

1 PDK1 disruptors and modulators: a patent review.Expert Opin Ther Pat. 2015 May;25(5):513-37.